1. Home
  2. HFWA vs PHAR Comparison

HFWA vs PHAR Comparison

Compare HFWA & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HFWA
  • PHAR
  • Stock Information
  • Founded
  • HFWA 1927
  • PHAR 1988
  • Country
  • HFWA United States
  • PHAR Netherlands
  • Employees
  • HFWA N/A
  • PHAR N/A
  • Industry
  • HFWA Banks
  • PHAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • HFWA Finance
  • PHAR Health Care
  • Exchange
  • HFWA Nasdaq
  • PHAR Nasdaq
  • Market Cap
  • HFWA 815.9M
  • PHAR 951.7M
  • IPO Year
  • HFWA N/A
  • PHAR N/A
  • Fundamental
  • Price
  • HFWA $25.19
  • PHAR $13.86
  • Analyst Decision
  • HFWA Hold
  • PHAR Strong Buy
  • Analyst Count
  • HFWA 3
  • PHAR 3
  • Target Price
  • HFWA $27.67
  • PHAR $30.00
  • AVG Volume (30 Days)
  • HFWA 175.9K
  • PHAR 13.2K
  • Earning Date
  • HFWA 10-23-2025
  • PHAR 10-23-2025
  • Dividend Yield
  • HFWA 3.84%
  • PHAR N/A
  • EPS Growth
  • HFWA 13.61
  • PHAR N/A
  • EPS
  • HFWA 1.43
  • PHAR N/A
  • Revenue
  • HFWA $221,312,000.00
  • PHAR $339,836,000.00
  • Revenue This Year
  • HFWA $22.09
  • PHAR $16.63
  • Revenue Next Year
  • HFWA $9.26
  • PHAR $6.77
  • P/E Ratio
  • HFWA $17.46
  • PHAR N/A
  • Revenue Growth
  • HFWA 3.23
  • PHAR 22.44
  • 52 Week Low
  • HFWA $19.84
  • PHAR $7.31
  • 52 Week High
  • HFWA $27.58
  • PHAR $17.08
  • Technical
  • Relative Strength Index (RSI)
  • HFWA 60.78
  • PHAR 51.52
  • Support Level
  • HFWA $23.53
  • PHAR $13.63
  • Resistance Level
  • HFWA $24.89
  • PHAR $15.27
  • Average True Range (ATR)
  • HFWA 0.76
  • PHAR 0.98
  • MACD
  • HFWA -0.02
  • PHAR -0.17
  • Stochastic Oscillator
  • HFWA 87.37
  • PHAR 16.68

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company through its subsidiary provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as noninterest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: